VOLUNTARY ANNOUNCEMENT MemoCarna OXIDE FILM SINGLE-RIVET PATENT FORAMEN OVALE OCCLUDER PRODUCT OBTAINS MEDICAL DEVICE REGISTRATION CERTIFICATE
Filed with HKEX · Stock code 2291 · · 2 pages · English
Summary by 6ix AI
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. has announced that its MemoCarna Oxide Film Single-Rivet Patent Foramen Ovale Occluder product has received a medical device registration certificate from the National Medical Products Administration of China. This product aims to enhance the stability of occlusion and reduce the risk of post-operative complications associated with patent foramen ovale. The company plans to continue developing interventional treatment options for structural heart disease. Shareholders and potential investors are advised to exercise caution regarding the product's impact on the company's financial performance.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. on 6ix
Earlier from LEPU ScienTech Medical Technology (Shanghai)
- Next Day Disclosure Return
- Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
Later from LEPU ScienTech Medical Technology (Shanghai)
- Further delay in despatch of circular in relation to major and connected transaction acquisition of 54.2384% equity interest in shanghai minwei biotechnology co., ltd.
- (1) Change of joint company secretaries, process agent and authorised representative; and (2) waiver from strict compliance with rules 3.28 and 8.17 of the listing rules
Follow LEPU ScienTech Medical Technology (Shanghai) into a list and get an email when it puts out news.
Follow LEPU ScienTech Medical Technology (Shanghai)